Europe Point-of-Care Molecular Diagnostics Market Share, Trends, Size, Segmentation And Forecast To 2028

Market Introduction

Point-of-care molecular diagnostics include portable devices, and assays & kits used to detect and diagnose diseases in human samples, such as throat swab, blood, serum, and stool. Molecular diagnostics are shifting from centralized laboratories to decentralized point-of-care molecular testing. Due to its simplicity, convenience, rapid turnaround time, and potential to improve patient outcomes, POCT is rapidly gaining traction.

Moreover, the growing demand for specific viral detection methods that consume less time for timely infection control is expected to bolster the market growth during the forecast period.

📚 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐂𝐨𝐩𝐲@ https://www.businessmarketinsights.com/sample/TIPRE00026190

In Europe, currently, the UK and Russia are the hardest-hit countries by the COVID-19 pandemic, followed by France, Spain, Italy, and Germany. The implementation of drastic measures and travel restrictions, including closing the borders, impacted the import and export of products, especially in the first half of 2020. The continuous spread of the disease has led to an elevated demand for advanced diagnostic solutions in Europe, thus boosting the adoption of point-of-care molecular diagnostic kits. Moreover, uninterrupted investments and business activities by industry players are also boosting the point-of-care molecular diagnostic market growth. In 2020, European Medicines Agency (EMA) approved ~97 medicines for the marketing authorization, of which 39 were novel drugs. In October 2020, Eurofins introduced PCR-based COVID-19 diagnostic tests with at-home, self-sampling options, in the for European market. In January 2020, European Union (EU) commission announced an emergency call, through which it awarded US$ 55.64 million to 18 research projects. Among these, 3 of the projects are receiving a total of US$ 7.39 million to develop effective, rapid point-of-care diagnostics.

📚𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭 𝐋𝐢𝐧𝐤 @ https://www.businessmarketinsights.com/reports/europe-point-of-care-molecular-diagnostics-market

𝐓𝐡𝐞 𝐋𝐢𝐬𝐭 𝐨𝐟 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬

bioMérieux SA

F. Hoffmann-La Roche Ltd.

Danaher Corporation

Enzo Biochem, Inc.

Abbott

binx health, Inc.

Meridian BioScience, Inc.

Biocartis

Quidel Corporation

Bio-Rad Laboratories, Inc

 

·      Segments Covered

By Product & Services

• Assays and Kits
• Instruments
• Services and Software

By Technology

• PCR
• Isothermal Nucleic Acid Amplification Technology
• Other Technologies

By Application

• Infectious Diseases
• Oncology
• Hematology
• Prenatal Testing
• Endocrinology
• Other Applications

By End User

• Hospitals and Clinics
• Diagnostic Laboratories
• Research and Academic Institutes

Key Drivers of Market Transformation:

• Speed and Efficiency:
• The hallmark of POC MDx is its ability to deliver results in minutes, rather than hours or days. This rapid turnaround time is critical in acute care settings, where timely diagnosis can be the difference between life and death.
• The simplicity and ease of use of POC MDx devices minimize the need for specialized training, enabling healthcare providers at all levels to perform molecular testing.
• Accessibility and Decentralization:
• POC MDx extends the reach of molecular diagnostics beyond traditional laboratory settings, bringing essential testing capabilities to clinics, emergency departments, physician's offices, and even patients' homes.
• This decentralization is particularly beneficial in underserved communities and remote areas, where access to centralized laboratories may be limited.
• Improved Patient Outcomes:
• By facilitating rapid diagnosis and timely treatment, POC MDx can significantly improve patient outcomes, reducing the risk of complications and enhancing the effectiveness of interventions.
• In infectious disease management, for example, rapid detection enables prompt isolation and treatment, curbing the spread of infections and safeguarding public health.
• The Impact of Pandemic Preparedness:
• The recent global pandemic has placed a very bright light on the need for rapid and accurate viral detection. The need for fast results, to quickly isolate and treat infected individuals has greatly increased the demand for POC MDx systems.
• The ability to have tests that can be used at many locations has proven to be vital.
• Growing Demand for Specific Viral Detection:
• The increasing prevalence of viral infections, coupled with the emergence of new and evolving pathogens, has fueled the demand for specific and sensitive viral detection methods.
• POC MDx plays a crucial role in enabling timely infection control measures, preventing outbreaks, and safeguarding public health.

The Future of POC MDx:

The POC MDx market is poised for continued growth and innovation, driven by advancements in molecular diagnostic technologies, the integration of digital health solutions, and the increasing demand for personalized medicine. As technology continues to improve, we can expect to see:

• Increased Automation:
• Further automation of POC MDx devices will simplify workflows, reduce the risk of human error, and enhance the efficiency of testing.
• Enhanced Connectivity:
• Seamless integration with electronic health records (EHRs) and other healthcare information systems will enable real-time data sharing and improved clinical decision-making.
• Expansion of Applications:
• The range of applications for POC MDx will continue to expand, encompassing a wider array of diseases and conditions, including cancer, cardiovascular disease, and genetic disorders.
• Home based testing innovations:
• The increased demand for at home testing, will drive the development of more user friendly and accurate at home tests.

 

 𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:

Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications